CureMelanoma.org
Toggle Navigation
Numbers & Timeline
Leading the Charge
Reflecting on a Decade of Progress and Future Heights
The Power of Synergy: Moving LAG-3 from Bench to Bedside
Adjuvant Therapy: Is More Better or is Less More?
Keeping Rare Melanomas Front and Center: Tebentafusp and Other Advances
Hot Rod Charlie and How Partnerships Move the Field Forward
2022 MRA Awards
Team Science Awards
Team Science Academic Industry Partnership Awards
Young Investigator Awards
Pilot Awards
Dermatology Fellows Awards
Dermatology Junior Faculty/Clinical Instructor Awards
The People of MRA
MRA Board of Directors
MRA Team
Melanoma > Exchange Community Leaders
MRA Scientific Advisory Panel 2022-2023
MRA Medical Advisory Panel 2022-2023
MRA Dermatology Council 2022-2023
Grant Review Committee 2022-2023
RARE Oversight Committee
Donors & Tributes
Donors & Supporters
Tributes & Memorials
Financials
2022 About MRA
Emmanuel Lerma
January 13, 2023
February 1, 2023
The People of MRA
Board of Directors
Click Here to View
MRA Team
Click Here to View
Melanoma > Exchange Community Leaders
Click Here to View
MRA Scientific Advisory Panel 2022 – 2023
Click Here to View
MRA Medical Advisory Panel 2022 – 2023
Click Here to View
MRA Dermatology Council Panel 2022 – 2023
Click Here to View
MRA Grant Review Committee 2022-2023
Click Here to View
RARE Oversight Committee
Click Here to View
Previous: Dermatology Junior Faculty/Clinical Instructor Awards
Next: MRA Board of Directors
CLOSE